{"nct_id":"NCT04195698","title":"Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2020-01-15","start_date_type":"ACTUAL","primary_completion_date":"2023-09-11","primary_completion_date_type":"ACTUAL","completion_date":"2023-09-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}